The U.S. Supreme Court has rejected a challenge by the tobacco industry to a federal law requiring that cigarette packages carry graphic warning labels, The Wall Street Journal reports.
Some pain doctors say they are concerned the Food and Drug Administration’s decision earlier this week not to approve generic versions of the original version of OxyContin could lead to less effective drugs that are potentially addictive, NPR reports.
Five U.S. senators are calling on the Food and Drug Administration to restrict the sale, distribution and marketing of e-cigarettes and other nicotine products to children and young adults.
Local governments can reduce excessive drinking by regulating the density of stores that sell alcohol, according to a new report.
Legalizing marijuana will not solve the country’s drug problem, the Director of the Office of National Drug Control Policy, Gil Kerlikowske, said Wednesday.
Banning smoking in public housing and units covered by rental assistance programs could save $521 million annually, according to a report by the Centers for Disease Control and Prevention.
Between 3 million and 5 million new patients could soon receive addiction treatment under the Affordable Care Act, according to the Associated Press. The change will have a major impact on treatment for drug and alcohol addiction.
Generic drug makers are waiting for the Food and Drug Administration to decide whether they must make tamper-resistant forms of OxyContin, or if they can produce the original version, The Wall Street Journal reports. OxyContin’s first patent expires Tuesday.
The federal government has been reducing funding for research on marijuana’s potential medical benefits, Bloomberg reports. Medical research funding for marijuana reached a peak of $131 million in 2007; it dropped to $91 million last year.
An international effort is underway to identify and ban new synthetic drugs earlier, Bloomberg Businessweek reports.